The Max Burdette Fibrolamellar Cancer Research Foundation
Search For "Healthcare" Companies in Germantown, Tennessee - Click Here Now!
Fibrolamellar Hepatocellular Carcinoma (sometimes Referred To As FHC Or FHCC) Is A Rare, Malignant Liver Tumor. The Tumor Is Typically Characterized By Fibrous Bands In A Unique ?lamellar? Pattern Under The Microscope. It Is Primarily Diagnosed In Patients From Their Young Teens To Late Twenties. It Was First Described In 1956 As A Variant Of Hepatocellular Carcinoma (HCC), A Primary Malignancy Of The Liver That Occurs Predominantly In Patients With Underlying Chronic Liver Disease, Alcohol Abuse (cirrhosis) And Infection By Hepatitis B Or C. Fibrolamellar Accounts For Only 1% To 5% Of All Cases Of Classic HCC. Currently, There Are No Known Causes Of Fibrolamellar, And It Is Very Difficult To Diagnose Because Its Symptoms Can Be Attributed To Many Things, Such As Abdominal Pain And Fatigue. Unlike HCC, There Is No Blood Test Available To Raise A Doctor?s Suspicion That The Symptoms May Be Caused By Something Other Than The Flu. For Most Patients With Fibrolamellar, The Diagnosis Is Made After A CT-scan Or MRI Of The Abdomen Is Performed, Long After All Other Tests Are Completed And Other Causes Ruled Out. At That Point, The Images Often Reveal A Large Liver Mass.
The Max Burdette Fibrolamellar Cancer Research Foundation in Germantown is a company that specializes in Health And Allied Services, Nec. Our records show it was established in Tennessee.
SaleSpider connects small businesses with big opportunities.Entrepreneur
Over 77.1 Million Businesses Worldwide